ŞAHUTOĞLU, T. Et Al. 2017. MP106 SERUM VEGFC LEVELS AS A CANDIDATE BIOMARKER OF HYPERVOLEMIA IN CHRONIC KIDNEY DISEASE. ERA-EDTA 54th Congress - Madrid June 3rd - 6th, 2017 , (Madrid, Spain), 465-467.

ŞAHUTOĞLU, T., SAKACI, T., HASBAL, N. B., AHBAP, E., KARA, E., Sumerkan, M. C., ... SEVİNÇ, M.(2017). MP106 SERUM VEGFC LEVELS AS A CANDIDATE BIOMARKER OF HYPERVOLEMIA IN CHRONIC KIDNEY DISEASE . ERA-EDTA 54th Congress - Madrid June 3rd - 6th, 2017 (pp.465-467). Madrid, Spain

ŞAHUTOĞLU, TUNCAY Et Al. "MP106 SERUM VEGFC LEVELS AS A CANDIDATE BIOMARKER OF HYPERVOLEMIA IN CHRONIC KIDNEY DISEASE," ERA-EDTA 54th Congress - Madrid June 3rd - 6th, 2017, Madrid, Spain, 2017

ŞAHUTOĞLU, TUNCAY Et Al. "MP106 SERUM VEGFC LEVELS AS A CANDIDATE BIOMARKER OF HYPERVOLEMIA IN CHRONIC KIDNEY DISEASE." ERA-EDTA 54th Congress - Madrid June 3rd - 6th, 2017 , Madrid, Spain, pp.465-467, 2017

ŞAHUTOĞLU, T. Et Al. (2017) . "MP106 SERUM VEGFC LEVELS AS A CANDIDATE BIOMARKER OF HYPERVOLEMIA IN CHRONIC KIDNEY DISEASE." ERA-EDTA 54th Congress - Madrid June 3rd - 6th, 2017 , Madrid, Spain, pp.465-467.

@conferencepaper{conferencepaper, author={TUNCAY ŞAHUTOĞLU Et Al. }, title={MP106 SERUM VEGFC LEVELS AS A CANDIDATE BIOMARKER OF HYPERVOLEMIA IN CHRONIC KIDNEY DISEASE}, congress name={ERA-EDTA 54th Congress - Madrid June 3rd - 6th, 2017}, city={Madrid}, country={Spain}, year={2017}, pages={465-467} }